Antimicrobial Activity of Nano-Encapsulated Essential Oils: Comparison to Non-Encapsulated Essential Oils

被引:7
作者
El Asbahani, A. [1 ,5 ]
Miladi, K. [3 ]
Addi, E. H. Ait [2 ]
Bitar, A. [3 ]
Casabianca, H. [4 ]
El Mousadik, A. [5 ]
Hartmann, D. J. [1 ]
Jilale, A. [5 ]
Renaud, F. N. R. [1 ]
Elaissari, A. [3 ]
机构
[1] Univ Lyon, ISPB Sch Pharm, Team I2B, UMR CNRS MATEIS 5510, F-69008 Lyon, France
[2] Univ Ibn Zohr, High Sch Technol, Agadir 80050, Morocco
[3] Univ Lyon, CNRS, UMR 5007, F-69622 Villeurbanne, France
[4] CNRS, Serv Cent Anal, Inst Analyt Sci, F-69622 Villeurbanne, France
[5] Ibn Zohr Univ, Fac Sci, Lab Biotechnol & Valorizat Nat Resources, Agadir 80060, Morocco
关键词
Nanoencapsulation; Nanoprecipitation; Essential Oils; Eudragit (R) RS 100; Antimicrobial Activity; Dermal Route; Pharmaceuticals and Cosmetics Applications;
D O I
10.1166/jcsb.2015.1118
中图分类号
O64 [物理化学(理论化学)、化学物理学]; O56 [分子物理学、原子物理学];
学科分类号
070203 ; 070304 ; 081704 ; 1406 ;
摘要
As fragile active components, essential oils should be encapsulated to solve several problems linked to their use, including toxicity, miscibility in aqueous medium, time-controlled release, formulations or preparations for various industries (pharmaceuticals, cosmetics, textiles, chemicals, food, etc.). Then, the aim of this study is to perform nano-encapsulation of selected essential oils and to compare their antimicrobial activities with the non-encapsulated ones. Essential oils of Thymus leptobotrys, Thymus satureoides, Pelargonium graveolens, Eugenia Caryophyllata and their major component Eugenol were first encapsulated by the nanoprecipitation technique using Eudragit RS 100 as coating polymer. This results in a final stable milky dispersion of essential oils nanocapsules having a final concentration of 4% (v/v). The formed nanoparticles have 110 nm averages in diameter particle size and possess positive zeta potential (approximately 81 mV). Chemical composition of these encapsulated essential oils was investigated by Gas Chromatography-Mass Spectrometry confirming similarities to the non-encapsulated ones. Antimicrobial assays against five bacterial strains, two yeasts and two moulds, confirm that the prepared nanoparticles exhibit, at a comparative concentration of 0.4% (v/v), relatively less antimicrobial activities (both bacteriostatic and fungistatic) than the non-encapsulated EOs. These results lead us to think to numerous applications of such essential oils particularly in the pharmaceutical and cosmetic domains.
引用
收藏
页码:39 / 48
页数:10
相关论文
共 52 条
  • [1] Anton N, 2008, J CONTROL RELEASE, V128, P185, DOI 10.1016/j.jconrel.2008.02.007
  • [2] Aristizabal M. C. B., 2013, J COLLOID SCI BIOTEC, V2, P263
  • [3] Biological effects of essential oils - A review
    Bakkali, F.
    Averbeck, S.
    Averbeck, D.
    Waomar, M.
    [J]. FOOD AND CHEMICAL TOXICOLOGY, 2008, 46 (02) : 446 - 475
  • [4] Baudoux D., 2010, COSMETIQUE INTELLIGE, P208
  • [5] Antimicrobial activity and chemical composition of Origanum glandulosum Desf. essential oil and extract obtained by microwave extraction:: Comparison with hydro distillation
    Bendahou, M.
    Muselli, A.
    Grignon-Dubois, M.
    Benyoucef, M.
    Desiobert, Jean-Marie
    Bernardini, Antoine-Francois
    Costa, Jean
    [J]. FOOD CHEMISTRY, 2008, 106 (01) : 132 - 139
  • [6] BENJILALI B, 1986, Plantes Medicinales et Phytotherapie, V20, P155
  • [7] Surface alteration of Saccharomyces cerevisiae induced by thymol and eugenol
    Bennis, S
    Chami, F
    Chami, N
    Bouchikhi, T
    Remmal, A
    [J]. LETTERS IN APPLIED MICROBIOLOGY, 2004, 38 (06) : 454 - 458
  • [8] Retention indices in the analysis of food aroma volatile compounds in temperature-programmed gas chromatography: Database creation and evaluation of precision and robustness
    Bianchi, Federica
    Careri, Maria
    Mangia, Alessandro
    Musci, Marilena
    [J]. JOURNAL OF SEPARATION SCIENCE, 2007, 30 (04) : 563 - 572
  • [9] Preparation and characterization of spironolactone-loaded nanocapsules for paediatric use
    Blouza, I. Limayem
    Charcosset, C.
    Sfar, S.
    Fessi, H.
    [J]. INTERNATIONAL JOURNAL OF PHARMACEUTICS, 2006, 325 (1-2) : 124 - 131
  • [10] Bontemps F., 2009, CAHIER 2, V2767, P2